Sponsored Content | Webinar | Advanced Visualization| August 29, 2017

WEBINAR: Multi-Modality 3-D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives

This webinar is supported by an educational grant from Philips Healthcare

Liver cancer advanced imaging. Webinar will cover new advances for more precise targeting of Liver Cancer.

The webinar "Multi-Modality 3D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives" focuses on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies. It introduces the audience to the mechanisms and principles of image analysis, outlines the growing role of machine learning for the therapeutic algorithm and the decision making processes in interventional oncology.

The webinar took place Oct. 3, 2017. Watch the recorded archive version of this webinar by registering.

Register to watch the archive version of this webinar

 

Statement of Purpose
Liver cancer is the second most common cause of cancer-related death worldwide and most cases are diagnosed at intermediate to advanced stages of the disease, making most patients no longer amenable to surgical therapies. Minimally invasive, loco-regional image guided therapies, such as chemoembolization, have become the mainstay therapy for such patients. These image-guided interventions also gave birth to the new field of interventional oncology, a subspecialty of interventional radiology which is increasingly considered as the new and fourth pillar of cancer care (next to medical, surgical and radiation oncology). The explosive growth of such therapies requires new and more efficient intra- and post-procedural imaging solutions. This webinar will focus on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies and introduce the audience to the mechanisms of action, principles of image analysis and the growing role of machine learning for the therapeutic algorithm and decision making in interventional oncology.

 

Learning Objectives
Upon completion of this activity, particpants will be able to:

• Summarize the principles and applications of image-guided minimally invasive tumor therapy.
• Describe the role of cancer imaging and multi-modality tumor tracking for local therapies of liver cancer.
• Review novel software-assisted 3-D quantitative tools to evaluate surrogate endpoints of therapeutic efficacy.
• Explain the growing role of machine learning in the automation and standardization of image analysis.

 

Intended Audience:
This activity is intended for oncologists, radiologist, nurse practitioners, biomedical engineers, and other clinicians interested in the management of liver cancer.

 

Presenter

Julius Chapiro, M.D., Ph.D.Julius Chapiro, M.D., Ph.D.
Research Scientist and Resident Physician
Yale School of Medicine

Dr. Chapiro is a research scientist at the Department of Radiology and Biomedical Imaging, Yale University School of Medicine. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin.

Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years.  He is the co-director of the Yale Radiology Research laboratory.

 

Register to watch the archive version of this webinar

Related Content

CT_Pediatric_Scan_Philips_Vereos_CT_RSNA 2016

Image courtesy of Philips Healthcare

News | Pediatric Imaging | December 10, 2019
December 10, 2019 — More than half of people who received...
Legislation ends surprise medical bills; funds Community Health Centers for five years; increases the purchasing age of tobacco to 21; lowers prescription drug and other medical costs by requiring more transparency and competition
News | Population Health | December 09, 2019
December 9, 2019 — Senate Health Committee Chairman...
 CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
News | Virtual and Augmented Reality | November 27, 2019
November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and m
With the HiRise, musculoskeletal radiologists and orthopedic specialists will be able to assess alignment of the total leg in three dimensions
News | Computed Tomography (CT) | November 25, 2019
November 25, 2019 — CurveBeam introduced the next level of weight-bearing...
The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept
News | Computed Tomography (CT) | November 21, 2019
November 21, 2019 — The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source
•	Sports Imaging is a unique specialty that allows radiologists to collaborate across the care continuum from detection to treatment

Image courtesy of Carestream Health

Feature | Radiology Business | November 18, 2019 | By Neelesh S. Prakash, M.D.
International Radiology Day (IDoR